Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
American Journal of Human Genetics|April 17, 1999
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levelsP Pajukanta, J D Terwilliger, M Perola, et al.Leukemia|November 30, 2012
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapyS Mustjoki, K Auvinen, A Kreutzman, et al.Bone Marrow Transplantation|April 14, 2015
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCTM Grövdal, H Nahi, G Gahrton, et al.Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.Nature Communications|June 22, 2017
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritisP Savola, T Kelkka, H L Rajala, et al.Leukemia|April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJ L Steegmann, M Baccarani, M Breccia, et al.Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.Leukemia|May 3, 2016
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patientsH Hjorth-Hansen, J Stentoft, J Richter, et al.Leukemia|January 19, 2013
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patientsS Mustjoki, J Richter, G Barbany, et al.Leukemia|October 7, 2015
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st studyA Hochhaus, G Rosti, N C P Cross, et al.Pageof 4